Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AZN:LSE since
announced
Transaction
value
Fusion Pharmaceuticals IncDeal completed19 Mar 202419 Mar 2024Deal completed1.79%2.30bn
Amolyt Pharma SASDeal completed14 Mar 202414 Mar 2024Deal completed0.15%1.05bn
Gracell Biotechnologies IncDeal completed26 Dec 202326 Dec 2023Deal completed0.36%1.10bn
Icosavax IncDeal completed12 Dec 202312 Dec 2023Deal completed3.74%862.87m
Data delayed at least 20 minutes, as of Nov 25 2024 15:23 GMT.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Caixa DTVM SAas of 30 Jun 2024268.41k0.00%
Daycoval Asset Management Administra��o de Recursos Ltda.as of 30 Jun 20242.99k0.00%
Data from 31 Jul 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.